Therapure Signs Manufacturing Deal With VBI Vaccines for COVID-19 Vaccine Candidates

Therapure Biomanufacturing announced the signing of an agreement with VBI Vaccines Inc. for the manufacture of their coronavirus vaccine candidates. Under this agreement, Therapure will be responsible for the biomanufacturing of the vaccine drug substance as well as the aseptic fill of the drug product at the Therapure facility in Mississauga, Ontario.